ORRU', MARISA MARGHERITA
 Distribuzione geografica
Continente #
EU - Europa 32.746
NA - Nord America 1.734
AS - Asia 195
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 34.684
Nazione #
IT - Italia 32.208
US - Stati Uniti d'America 1.715
UA - Ucraina 191
CN - Cina 183
SE - Svezia 164
FI - Finlandia 55
DE - Germania 52
GB - Regno Unito 35
CA - Canada 19
FR - Francia 18
BE - Belgio 12
SG - Singapore 5
AU - Australia 4
EU - Europa 3
NL - Olanda 3
BD - Bangladesh 2
CH - Svizzera 2
KR - Corea 2
PL - Polonia 2
RU - Federazione Russa 2
BR - Brasile 1
IE - Irlanda 1
IN - India 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
TR - Turchia 1
Totale 34.684
Città #
Cagliari 31.944
Fairfield 270
Woodbridge 175
Wilmington 135
Chandler 130
Houston 117
Nyköping 116
Ashburn 110
Ann Arbor 108
Seattle 108
Jacksonville 104
Cambridge 92
Dearborn 73
Beijing 41
Nanjing 41
Boardman 26
Boston 23
Helsinki 23
San Diego 17
Toronto 14
Brussels 12
Milan 12
Molise 11
Shanghai 11
Shenyang 9
Jiaxing 8
Tianjin 8
Changsha 7
Hebei 7
Hefei 7
Settimo Torinese 6
Guangzhou 5
Mountain View 5
Norwalk 5
Redwood City 5
Rome 5
Falls Church 4
Kilburn 4
Kunming 4
Nanchang 4
New York 4
Orange 4
Palermo 4
Verona 4
Alcamo 3
Alghero 3
Auburn Hills 3
Jinan 3
Mogliano Veneto 3
Sassari 3
Taizhou 3
Frosinone 2
Gimigliano 2
Hanover 2
Hounslow 2
London 2
Messina 2
Monserrato 2
Naples 2
Ningbo 2
Pieve 2
Ponte Buggianese 2
Rimini 2
San Felice Sul Panaro 2
San Germano Vercellese 2
Santa Venerina 2
Segrate 2
Torino 2
Villeparisis 2
Washington 2
Zhengzhou 2
Acton 1
Arzano 1
Bastia 1
Belleville 1
Bologna 1
Brescia 1
Caiazzo 1
Carmagnola 1
Cesena 1
Chaoyang 1
Chongqing 1
Cogorno 1
Condé-sur-huisne 1
Corona 1
Dallas 1
Delft 1
Fano 1
Ferrara 1
Foligno 1
Forlì 1
Genova 1
Genzano di Roma 1
Hangzhou 1
Indiana 1
Islington 1
Kelowna 1
Lachine 1
Los Angeles 1
Manila 1
Totale 33.912
Nome #
Overview of elagolix for the treatment of endometriosis 3.102
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 2.628
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.270
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.606
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.573
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.403
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.309
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.207
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.205
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.162
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.147
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.135
Pattern of bone markers during pregnancy and their changes after delivery. 1.131
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.061
The treatment of polycystic ovary syndrome 1.045
Correlazioni tra composizione corporea ed età 1.003
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women 984
La scelta razionale: terapia ormonale a basso dosaggio 957
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome 850
null 814
Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. 747
Contraccezione estroprogestinica dopo il 2000. L'utilizzazione dei bassissimi dosaggi 736
Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome 723
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies 593
Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic-ovary-syndrome 555
Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause 551
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome 551
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy 529
Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome 520
Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women 514
Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase 506
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism 498
Chorioamnionitis 112
Totale 34.727
Categoria #
all - tutte 41.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019604 0 0 0 0 0 0 0 137 84 82 150 151
2019/20209.922 553 260 42 126 4.374 2.435 1.332 259 114 86 147 194
2020/20219.811 244 306 274 3.604 2.383 925 674 441 195 284 318 163
2021/20222.099 153 215 78 108 209 262 180 63 100 171 315 245
2022/20231.987 264 203 223 157 219 221 84 169 125 92 154 76
2023/20241.740 129 103 141 188 253 389 403 134 0 0 0 0
Totale 34.727